Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer, Arvinas lose interest in commercializing PROTAC drug
Having already stripped development plans for vepdegestrant on the back of mixed data, Pfizer and Arvinas decided to wash their hands of the drug.
James Waldron
Sep 18, 2025 7:35am
Sanofi becomes latest pharma to hold fire on UK R&D investments
Sep 15, 2025 10:14am
Pfizer, Valneva boosted by updated Lyme vaccine data
Sep 3, 2025 10:19am
Pfizer's SCD drug fails ph. 3 study in latest blow to GBT legacy
Aug 18, 2025 7:31am
Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial
Aug 7, 2025 6:30am
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm